Bausch Health Companies (BHC) Current Deferred Revenue (2009 - 2012)
Bausch Health Companies (BHC) posted Current Deferred Revenue of $7.0 million for Q4 2012, down 61.24% sequentially from $18.1 million in Q3 2012, and down 44.99% YoY from $12.8 million in Q1 2012.
Bausch Health Companies (BHC) Current Deferred Revenue (2009 - 2012) Analysis & Trends
Bausch Health Companies has reported Current Deferred Revenue for 4 years, with the latest figure at $7.0 million in Q4 2012.
- Quarterly Current Deferred Revenue fell 44.99% year-over-year to $7.0 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $7.0 million (down 44.99% YoY) and the FY2012 annual result came in at $7.0 million, down 44.99% from the prior year.
- Current Deferred Revenue declined to $7.0 million in Q4 2012 per BHC's latest filing, from $18.1 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $23.3 million in Q3 2010 and troughed at $7.0 million in Q2 2012.
- A 4-year average of $16.5 million and a median of $18.6 million in 2011 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 23.02% in 2012, down 63.12% in 2012.
- Over 4 years, Current Deferred Revenue stood at $21.8 million in 2009, then decreased by 1.44% to $21.5 million in 2010, then slumped by 40.6% to $12.8 million in 2011, then sank by 44.99% to $7.0 million in 2012.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $7.0 million, $18.1 million, and $7.0 million for Q4 2012, Q3 2012, and Q2 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 7.03 Mn |
| Sep 30, 2012 | 18.14 Mn |
| Jun 30, 2012 | 7.03 Mn |
| Mar 31, 2012 | 8.73 Mn |
| Dec 31, 2011 | 12.78 Mn |
| Sep 30, 2011 | 14.75 Mn |
| Jun 30, 2011 | 19.06 Mn |
| Mar 31, 2011 | 22.85 Mn |
| Dec 31, 2010 | 21.52 Mn |
| Sep 30, 2010 | 23.33 Mn |
| Jun 30, 2010 | 21.13 Mn |
| Dec 31, 2009 | 21.83 Mn |